| Literature DB >> 33437589 |
Fei Teng1, Martin Fussenegger1,2.
Abstract
Extracellular vesicles (EVs) are biocompatible, nano-sized secreted vesicles containing many types of biomolecules, including proteins, RNAs, DNAs, lipids, and metabolites. Their low immunogenicity and ability to functionally modify recipient cells by transferring diverse bioactive constituents make them an excellent candidate for a next-generation drug delivery system. Here, the recent advances in EV biology and emerging strategies of EV bioengineering are summarized, and the prospects for clinical translation of bioengineered EVs and the challenges to be overcome are discussed.Entities:
Keywords: bioengineering; delivery systems; exosomes; extracellular vesicles; microvesicles
Year: 2020 PMID: 33437589 PMCID: PMC7788585 DOI: 10.1002/advs.202003505
Source DB: PubMed Journal: Adv Sci (Weinh) ISSN: 2198-3844 Impact factor: 17.521